Metronidazole - Appili Therapeutics
At a glance
- Drug Originator Appili Therapeutics
- Drug Licenced by Long Zone Holdings; Saptalis Pharmaceuticals
- Drug Class Antibacterials; Antiprotozoals; Nitroimidazoles; Radiosensitisers; Skin disorder therapies; Small molecules
- Mechanism of Action DNA synthesis inhibitors
- USA Patent Applicants SAPTALIS PHARMS
- USA Patents 1
- NDAs 1
- International Patents 5
Disclaimer